Sector consensus Compass Therapeutics, Inc.
Stocks
CMPX
US20454B1044
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
16:00:00 2026-09-28 EDT
|
5-day change | 1st Jan Change | ||
| 1.110 USD | -1.77% |
|
-39.01% | -79.33% |
| 09-23 | Compass Therapeutics Shares Drop After Downgrade From Wedbush | MT |
| 09-23 | Wedbush Downgrades Compass Therapeutics to Neutral From Outperform, Cuts Price Target to $1 From $5 | MT |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | 5.5 | +386.73% | 12 | ||||||
| 187.07 | +15.19% | 18 | ||||||
| 1,175.3 | +22.02% | 15 | ||||||
| 49.73 | +9.85% | 24 | ||||||
| 199.04 | +68.92% | 23 | ||||||
| 103.07 | +18.94% | 20 | ||||||
| 2,453.79 | +7.76% | 15 | ||||||
| 1,397.26 | +20.98% | 8 | ||||||
| 53.69 | -7.69% | 16 | ||||||
| 619.67 | +32.69% | 19 | ||||||
| 21.61 | +83.3% | 13 | ||||||
| 682.11 | +32.05% | 18 | ||||||
| 133.02 | +66.15% | 21 | ||||||
| 107.23 | +62.67% | 13 | ||||||
| 109.9 | +69.97% | 20 | ||||||
| 12.75 | +51.07% | 4 | ||||||
| 109 | +93.92% | 9 | ||||||
| 100.11 | +60.46% | 16 | ||||||
| 120.08 | +40.13% | 13 | ||||||
| - | - | - | - | - | ||||
| Average | 402.1 | +59.74% | 16 | ||||||
| Weighted average by Cap. | 523.55 | +31.06% | 17 |
- Stock Market
- Stocks
- CMPX Stock
- Sector Compass Therapeutics, Inc.
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
